The next major wave of class action settlements will be driven by addiction claims, not privacy violations. The numbers already make this clear: the Purdue Pharma settlement alone reached $7.4 billion with all 55 U.S. states and territories in January 2025, while the top ten privacy settlements from 2024 combined totaled just $2.01 billion. Addiction litigation—both pharmaceutical opioid cases still pending and emerging social media addiction claims—represents a far larger problem affecting far more people, with deeper legal liability and stronger causation evidence than most privacy breaches. While privacy settlements have plateaued around $2 billion annually over the last three years, addiction settlements continue to grow in both scale and scope.
The shift reflects a fundamental difference in how courts and regulators view these harms. Privacy violations cause mostly financial or reputational injury; addiction causes illness, death, and family destruction. That difference matters enormously when judges and juries are deciding damages. Additionally, addiction settlements come with mandatory spending requirements—the Purdue settlement and broader opioid framework require 85% of funds go directly to treatment and prevention—which means these cases stay in the public consciousness longer and drive ongoing policy change.
Table of Contents
- Why Are Addiction Settlements So Much Larger Than Privacy Settlements?
- The Opioid Litigation Machine That Won’t Stop
- What the Purdue Settlement Tells Us About Addiction Law
- The Next Wave—Social Media Addiction and Tech Companies
- Why Privacy Settlements Have Plateaued
- The Spending Mandate Advantage
- The Future—Addiction Dominance Will Likely Continue
- Frequently Asked Questions
Why Are Addiction Settlements So Much Larger Than Privacy Settlements?
The scale gap is striking. Purdue Pharma’s $7.4 billion settlement, approved in January 2025, exceeds all of 2024’s top ten privacy settlements combined. That single deal against one pharmaceutical company dwarfs Meta’s largest privacy settlement of $725 million (which covered biometric and user privacy violations). Even within broader context, the entire opioid settlement framework—$50 billion-plus over 18 years across pharmaceutical distributors and manufacturers—makes the cumulative privacy litigation landscape look modest by comparison. This gap exists because addiction cases involve demonstrable, systemic harm with clear causal chains.
The opioid epidemic killed more than 100,000 Americans; courts found that manufacturers misrepresented addiction risk, paid doctors to over-prescribe, and knew their products were driving addiction rates upward. Those facts, once established, translate into enormous damages because the harm is quantifiable: overdose deaths, treatment costs, lost productivity. Privacy cases, by contrast, ask courts to assign dollar values to exposed data or biometric information—harms that are real but harder to price. A breached SSN causes identity theft risk; a leaked photo causes emotional harm. Neither translates into the same scale of proven damages as death and family destruction.
The Opioid Litigation Machine That Won’t Stop
Despite the landmark settlements of recent years, opioid litigation remains extraordinarily active. As of April 2025, 2,985 lawsuits are still pending in the opioid multidistrict litigation (MDL). these include cases from smaller pharmacy chains, individual hospitals, Native American tribes, and cities that missed earlier settlement windows. Each new case follows a similar playbook: establish that the defendant sold dangerous products, misrepresented their risks, and profited from addiction. The evidence now exists in discovery from earlier cases, which means lawyers can move faster and courts are more educated about the liability patterns.
However, not all remaining opioid cases will settle at Purdue-scale numbers. Cases involving smaller defendants, narrower geographic scope, or less direct involvement in marketing campaigns will likely settle for smaller amounts. The $7.4 billion Purdue settlement was massive partly because the Sackler family’s personal involvement in the company and their direct role in marketing strategy created extraordinary liability. Future settlements involving mid-tier distributors or generic manufacturers will be smaller, though likely still in the hundreds of millions. The key point: the litigation pipeline remains strong and will generate significant settlements through 2027 and beyond.
What the Purdue Settlement Tells Us About Addiction Law
The Purdue Pharma settlement offers a template for how addiction settlements work in practice. Purdue itself will contribute approximately $900 million in the first payment (expected early 2026), with the Sackler family contributing $1.5 billion over time. But the settlement also imposed a hard requirement: 85% of all funds must be spent on addiction treatment, prevention, and recovery programs. That mandate exists in the broader opioid settlement framework too, including the $21 billion settlement from the three major pharmaceutical distributors and the $5 billion Johnson & Johnson settlement. This spending mandate makes addiction settlements different from privacy settlements in a crucial way.
When Meta pays $725 million for a privacy violation, companies have discretion in how the money flows—typically divided among plaintiffs. But when states receive opioid settlement funds, they’re legally required to spend 85% on treatment clinics, medication-assisted therapy, and prevention education. That money stays visible in the community, funds ongoing recovery infrastructure, and keeps the issue in the public eye. From a plaintiff’s perspective, it also means settlement funds actually address the underlying problem rather than just compensating victims. This structural difference helps explain why addiction settlements capture more political and social attention than privacy cases.
The Next Wave—Social Media Addiction and Tech Companies
While opioid litigation dominates the current addiction settlement landscape, the next growth area is emerging now: social media and tech companies being sued for addictive platform design. TikTok, Instagram, and Facebook face growing litigation alleging that autoplay features, infinite scroll, algorithmic content recommendation, and push notifications are deliberately engineered to maximize engagement and addict users—particularly teenagers. The claimed harms are real: anxiety, depression, sleep loss, declining school performance, and worsening mental health during critical developmental years. These cases are still largely in early stages, but they follow a dangerous liability pattern for tech companies.
Unlike privacy breaches (where companies might argue they didn’t intend to leak data), addiction design is intentional. Internal documents from Meta and other platforms show executives discussing “engagement metrics” and “hook design.” Plaintiffs’ lawyers now have precedent from tobacco and opioid cases showing how courts treat intentional addiction design. The addiction playbook—prove the company knew about harm, continued the behavior for profit, and concealed the risks—applies directly to social media. If even one major platform settles a teen addiction case for $500 million or more, it could trigger a cascade of similar claims. That’s when addiction settlements will clearly dominate the settlement landscape.
Why Privacy Settlements Have Plateaued
Privacy litigation hit $2.01 billion in 2024, up from prior years, but has remained relatively stable—not growing exponentially like addiction cases. The constraint is legal and practical: proving damages in privacy cases is genuinely hard. When a company loses customer data, what exactly did each person lose? Data brokers already sell similar information; courts struggle to assign individual damages. When a company uses biometric data without consent, is that worth $10 per person or $100 per person? Juries disagree, which creates settlement uncertainty. Additionally, privacy regulations like CCPA and GDPR have made large-scale data breaches less likely (though not impossible).
Companies now invest in security, and regulators penalize breaches heavily before class actions even begin. The low-hanging fruit in privacy litigation—companies that carelessly exposed massive datasets—is being addressed through regulatory enforcement first. What remains are harder cases: companies that followed the letter of privacy law but violated its spirit through dark patterns or aggressive data collection. Those cases take longer to litigate and generate smaller settlements because the company’s conduct sits in a legal gray zone. Privacy litigation isn’t disappearing, but it’s not exploding because the underlying problem is being managed through regulation and tech investment.
The Spending Mandate Advantage
One structural factor gives addiction settlements a long-term advantage over privacy cases: the mandatory spending requirement. As noted earlier, 85% of opioid settlement funds must fund treatment and recovery. This differs from privacy settlements, where defendant companies typically pay directly to plaintiffs or into a claims fund, with no mandate on downstream use. From a settlement economics perspective, this matters enormously.
When a state receives $100 million in opioid settlement funds, $85 million automatically flows to addiction services—building treatment capacity, funding medication-assisted therapy, supporting peer recovery programs. Those funded programs then improve public health, which reduces future costs on the health system and criminal justice system. Courts and legislators view this as virtuous: the settlement directly addresses the harm. In privacy cases, the $100 million settlement may fund plaintiff payments or a monitoring service, but it doesn’t create systemic change the way addiction spending does. This makes addiction settlements more politically durable and more likely to trigger follow-on litigation, because the problem is being addressed visibly.
The Future—Addiction Dominance Will Likely Continue
Looking forward to 2026 and beyond, addiction settlements will almost certainly represent a larger share of the total settlement landscape than privacy cases. The opioid MDL still has 2,985 pending lawsuits; many will settle over the next 18 months. Social media addiction cases are moving toward critical junctures—discovery is expanding, plaintiffs are filing amended complaints with stronger evidence of intentional design, and experts are building causation models linking platform features to mental health harms.
When the first major social media settlement lands—and it will—it will likely be in the $300 million to $1 billion range, which will shock observers and launch dozens of similar claims against other platforms. Meanwhile, privacy litigation will continue at its current pace: steady, important, but not explosive. The landscape will diversify—more cases will focus on specific gray-area practices like dark patterns, algorithmic manipulation, and cross-platform data sharing rather than straightforward breaches. But the dollar volumes won’t spike the way addiction settlements have, because the legal machinery for settling addiction cases (quantifying harms, imposing spending mandates, addressing systemic risk) is already in place and functioning at scale.
Frequently Asked Questions
Can I still file a claim in the Purdue Pharma settlement?
The Purdue settlement closed to new claimants in 2024. However, thousands of other opioid settlements remain active, including cases against smaller manufacturers and distributors. Check the Opioid Settlement Tracker or consult with a settlement claims attorney to see if you qualify for any ongoing opioid case or settlement program in your state.
How much money do individual addiction victims typically receive from settlements?
Settlement payouts vary widely depending on the specific case and victim circumstances. In opioid settlements, individual victims typically receive between $5,000 and $50,000, though some cases offer more for documented overdose survivors. Most settlement funds flow to states and treatment programs (the 85% mandate), not directly to individuals.
Are social media addiction cases actually going to settle, or is this speculative?
Several lawsuits against TikTok, Instagram, and Facebook have survived motions to dismiss and are in active discovery. The legal playbook (proving intentional design for addiction, known harms, concealed risks) mirrors successful opioid litigation. Settlements may come in 2026-2027 if discovery produces smoking-gun evidence of intentional addictive design, which appears likely based on available internal documents.
How is an addiction settlement different from a privacy settlement for a victim?
Structurally, addiction settlements often funnel the majority of money into treatment programs and public health infrastructure that benefit broad communities, not just claimants. Privacy settlements typically distribute money more directly to affected individuals. From a victim perspective, addiction settlements may deliver less direct payment but more systemic change in how the harmful industry operates.
Should I wait for social media addiction settlements, or pursue opioid cases now?
If you have a valid opioid claim, pursue it now while cases are still actively settling. Opioid litigation is mature and moving toward conclusion. Social media addiction cases are still 1-2 years from probable settlement, so waiting for those is not a practical strategy if you have a current claim.
What happens to opioid settlement money if my state doesn’t spend it on treatment?
The settlement agreement requires 85% of funds be spent on treatment and recovery. States that fail to comply face legal challenges and reputational pressure from attorneys general and advocacy groups. Some states have faced criticism for slow spending, but the mandate remains enforceable.